Respiratory

With COPD Being the Fourth Leading Cause of Death in the United States, Effective COPD Treatments Are Necessary1

Chronic obstructive pulmonary disease (COPD) is associated with many other chronic diseases, including cardiovascular diseases and diabetes.
  • 6.3%
    of US adults have been diagnosed with COPD2
  • >50%
    of patients with COPD are under the age of 652
  • 63%
    of all COPD-related hospital stays were due to an acute exacerbation, in one study3
  • 20.1%
    of patients with COPD are readmitted within 30 days, making COPD one of the 10 conditions with the highest readmission rates in the US4

Learn more about rising COPD readmissions in this recent report from the Healthcare Cost and Utilization Project

Respiratory Hospital

Learn more about rising COPD readmissions in this recent report from the Healthcare Cost and Utilization Project

The GOLD Strategy Report recommends considering inhaler choice before escalating treatment

When a patient's response to COPD treatment is inadequate, the GOLD Strategy Report recommends the following5:

Respiratory Inhaler Technique

Evaluate patient’s adherence and inhaler technique

Respiratory Switch Inhaler Molecule

Switch inhaler molecule within the same class

Explore the GOLD Strategy Report for details on guideline recommendations

Use these instructions on how to implement recommendations from the GOLD Strategy Report into your EHR

Incorporate GOLD into your EHR

Identify patients with COPD within your system

Learn How health systems increased care coordination to improve the management of their population with COPD

 

EHR=electronic health record; GOLD=Global Initiative for Chronic Obstructive Lung Disease.

 

1. Kochanek K, Murphy SL, Xu J, Arias E. National Center for Health Statistics. National Vital Statistics Report - Deaths: Final Data for 2017. https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_09-508.pdf. Published June 24, 2019. Accessed September 20, 2020. 2. Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease among adults—United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(46):938-943. 3. Wier LM, Elixhauser A, Pfuntner A, et al. Overview of Hospitalizations among Patients with COPD, 2008. Healthcare Cost and Utilization Project Statistical Brief #106. 2011. https://www.ncbi.nlm.nih.gov/books/NBK53969/. 4. Fingar KR, Barrett ML, Jiang HJ. A Comparison of All-Cause 7-Day and 30-Day Readmissions, 2014. Healthcare Cost and Utilization Project Statistical Brief #230. October 2017. www.hcup-us.ahrq.gov/reports/statbriefs/sb230-7-Day-Versus-30-Day-Readmissions.pdf. 5. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021 report. https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed March 23, 2021.